Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217

European Heart Journal
Marianne BennBørge G Nordestgaard

Abstract

Ideally, familial hypercholesterolaemia (FH) is diagnosed by testing for mutations that decrease the catabolism of low-density lipoprotein (LDL) cholesterol; however, genetic testing is not universally available. The aim of the present study was to assess the frequency and predictors of FH causing mutations in 98 098 participants from the general population, the Copenhagen General Population Study. We genotyped for LDLR[W23X;W66G;W556S] and APOB[R3500Q] accounting for 38.7% of pathogenic FH mutations in Copenhagen. Clinical FH assessment excluded mutation information. The prevalence of the four FH mutations was 0.18% (1:565), suggesting a total prevalence of FH mutations of 0.46% (1:217). Using the Dutch Lipid Clinic Network (DLCN) criteria, odds ratios for an FH mutation were 439 (95% CI: 170-1 138) for definite FH, 90 (53-152) for probable FH, and 18 (13-25) for possible FH vs. unlikely FH. Using the Simon Broome criteria, the odds ratio was 27 (20-36) for possible vs. unlikely FH, and using the Make Early Diagnosis to Prevent Early Death (MEDPED) criteria, 40 (28-58) for probable vs. unlikely FH. Odds ratios for an FH mutation were 17 (9-31) for LDL-cholesterol of 4-4.9 mmol/L, 69 (37-126) for LDL-cholesterol of 5-5.9 mmol/L...Continue Reading

References

May 29, 1998·The New England Journal of Medicine·A Tybjaerg-HansenB G Nordestgaard
Jan 26, 2002·Human Genetics·S W FouchierJ P Kastelein
Jul 16, 2003·The American Journal of Cardiology·Peter H JonesUNKNOWN STELLAR Study Group
Nov 5, 2003·Journal of Hypertension·Judith A Whitworth, UNKNOWN World Health Organization, International Society of Hypertension Writing Group
Aug 24, 2004·American Journal of Epidemiology·Melissa A AustinSteve E Humphries
Aug 24, 2004·American Journal of Epidemiology·Melissa A AustinSteve E Humphries
Nov 6, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Anne Tybjaerg-HansenBørge G Nordestgaard
Dec 5, 2006·Journal of Medical Genetics·S E HumphriesUNKNOWN Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Børge G NordestgaardAnne Tybjaerg-Hansen
Sep 15, 2007·BMJ : British Medical Journal·David S WaldNicholas J Wald
Oct 23, 2008·The American Journal of Cardiology·Fernando CiveiraMiguel Pocovi
Oct 31, 2008·The New England Journal of Medicine·Jeppe ZachoBørge G Nordestgaard
Sep 16, 2011·Atherosclerosis. Supplements·Gerald F WattsUNKNOWN Familial Hypercholesterolaemia Australasia Network Consensus Group (Australian Atherosclerosis Society)
Aug 16, 2012·The Journal of Clinical Endocrinology and Metabolism·Marianne BennBørge G Nordestgaard
Jan 15, 2014·International Journal of Cardiology·Gerald F WattsJohn J P Kastelein
Dec 3, 2014·The Canadian Journal of Cardiology·UNKNOWN Primary Panel:Julie St-Pierre
Mar 21, 2015·International Journal of Cardiology·Gerald F WattsMelinda J Carrington

❮ Previous
Next ❯

Citations

May 18, 2016·Indian Journal of Endocrinology and Metabolism·Sanjay KalraRakesh Sahay
May 3, 2016·European Heart Journal·Thomas F Lüscher
Apr 20, 2016·European Heart Journal·Kausik K Ray, G Kees Hovingh
Aug 16, 2016·The Canadian Journal of Cardiology·Manal AlkindiJacques Genest
Oct 30, 2016·The Canadian Journal of Cardiology·Jacques Genest
May 18, 2016·The Lancet. Diabetes & Endocrinology·Anne LangstedBørge G Nordestgaard
Jul 9, 2016·Current Opinion in Lipidology·Kate HaralambosIan F W McDowell
Jul 16, 2016·Journal of the American College of Cardiology·Joshua W Knowles
Jul 16, 2016·Journal of the American College of Cardiology·Joost BesselingBarbara A Hutten
Oct 12, 2016·Heart, Lung & Circulation·Alistair W Vickery, Gerald F Watts
Jan 6, 2017·Nature Reviews. Cardiology·Daniel I Swerdlow, Steve E Humphries
Feb 9, 2017·Current Opinion in Lipidology·Iris KindtJoshua W Knowles
Feb 9, 2017·Current Opinion in Cardiology·Caroline S BruikmanJohn J P Kastelein
May 20, 2017·Expert Review of Molecular Diagnostics·Michael A Iacocca, Robert A Hegele
Nov 3, 2016·Journal of Lipid Research·Børge G Nordestgaard, Anne Langsted
Oct 26, 2016·Journal of Lipid Research·Roopa MehtaCarlos A Aguilar-Salinas
Jul 19, 2017·European Journal of Preventive Cardiology·Gerald F Watts, Jing Pang
Nov 9, 2016·Journal of Medical Genetics·Sarah LeighSteve E Humphries
Feb 7, 2018·The Journal of Clinical Endocrinology and Metabolism·Dick C ChanGerald F Watts
Apr 5, 2018·Cardiovascular Research·Jeanette ErdmannHeribert Schunkert
Jan 23, 2018·Current Opinion in Lipidology·Andrea VoltaAldo Grefhorst
Jan 26, 2018·Current Opinion in Lipidology·Natalie SmythFrederick J Raal
Jan 13, 2018·Journal of Cellular Physiology·Hamid MollazadehAmirhossein Sahebkar
Oct 22, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Jian WangRobert A Hegele
Jun 28, 2017·Journal of the American Heart Association·Paul N Hopkins
Dec 10, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Jian-Jun LiQian Dong
Feb 21, 2018·Circulation·Jan-Willem BalderJan Albert Kuivenhoven
Jul 7, 2017·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Nader ParsaMaurizio Trevisan
Jul 1, 2016·Circulation·Fatima Rodriguez, Joshua W Knowles
Nov 2, 2018·Current Opinion in Lipidology·Pedro MataLeopoldo Pérez de Isla
Mar 27, 2018·Annals of Medicine·Najmeh AhangariAlireza Pasdar
Dec 21, 2018·Circulation. Genomic and Precision Medicine·Michael G LevinScott M Damrauer
Feb 13, 2019·The Journal of Clinical Endocrinology and Metabolism·Sabina BeheshtiBørge G Nordestgaard
Mar 5, 2019·Current Pharmaceutical Design·Yunyun YangYanwen Qin
Jun 7, 2019·Molecular Diagnosis & Therapy·Ye-Xuan CaoJian-Jun Li
Oct 17, 2019·Molecular Genetics & Genomic Medicine·Karen H Y WongClive R Pullinger

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.